Pegylated Liposomal Doxorubicin In Combination With Ecteinescidin 743

摘要

Disclosed is the use of ET-743 in the preparation of a medicament for an effective treatment of cancer of the human body by combination therapy employing an effective therapeutic amount of ET-743 with an effective therapeutic amount of Pegylated Liposomal form of the anthracycline Doxorubicin ("PLD").